A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma
Anais Brasileiros de Dermatologia · 2024
DOI: 10.1016/j.abd.2022.10.015 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anais Brasileiros de Dermatologia, 2024. Verfasst von Shohei Igari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Fukushima Medical University, Fukushima, Japan. Electronic address: shohey19@fmu.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Melanoma, Skin Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan. Electronic address: shohey19@fmu.ac.jp.
- Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Zitieren
APA
Igari, S., Yamamoto, M., Kikuchi, N., Ohtsuka, M., & Yamamoto, T. (2024). A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2022.10.015
Vancouver
Igari S, Yamamoto M, Kikuchi N, Ohtsuka M, Yamamoto T. A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma. Anais Brasileiros de Dermatologia. 2024. doi:10.1016/j.abd.2022.10.015
BibTeX
@article{Igari2024,
author = {Igari, Shohei and Yamamoto, Miyuki and Kikuchi, Nobuyuki and Ohtsuka, Mikio and Yamamoto, Toshiyuki},
title = {A case of ruptured hepatic metastases during pembrolizumab administration for cutaneous malignant melanoma},
journal = {Anais Brasileiros de Dermatologia},
year = {2024},
doi = {10.1016/j.abd.2022.10.015}
}
EUVIMED